Category Archives: THE FUTURE OF PBM/LLLT

My vision of the future for PBM/LLLT

Low Level Laser (LLLT) “regenerates teeth”

Low level laser regenerates teeth TV, radio and newspapers all over the world got very excited last week reporting that “laser regenerates teeth” following a Harvard study. The study showed that LLLT stimulates the stem cells resident in the tooth pulp to form dentin (for details click below). This is the highest profile announcement for any LLLT paper ever and will add significant awareness and credibility for everyone in the field. Congratulations and huge thanks to the author Dr Praveen Arany B.D.S., M.D.S., M.M.Sc., Ph.D. who is now a Clinical Investigator at NIH.

Posted in THE FUTURE OF PBM/LLLT | on Low Level Laser (LLLT) “regenerates teeth”

THOR at Harvard MIT

David Sengeh has been developing powered limbs at MIT for amputees (like the bionic man). Where the powered limb attaches to the body (the stump of the original leg) it gets very sore. David has been using our standard THOR products to heal the stump and reduce pain. It works very well, though it takes a lot of time to treat the whole area. I am in Boston now to help David start clinical trials with a new device we designed that will treat the whole stump. The amputee puts the the leg stump into the LED treatment cylinder and gets a complete treatment in just one minute :-)

MIT

Posted in Special Feature, THE FUTURE OF PBM/LLLT | 5 Comments

Mike Hamblin Harvard LLLT TBI video interview

LLLT for Traumatic Brain Injury (TBI) by Prof. Michael Hamblin, Wellman Centre for Photomedicine, Harvard Medical School.

Posted in Interviews, THE FUTURE OF PBM/LLLT, Video of the Week | 8 Comments

LLLT LED patch for Alzheimer’s

Clarimedix Inc., will present results of animal studies on its LLLT LED patch for Alzheimer’s disease at the International Conference of the Alzheimer’s & Parkinson’s Disease Conference in Barcelona on March 9.

Posted in THE FUTURE OF PBM/LLLT | on LLLT LED patch for Alzheimer’s

The next decade of LLLT – the barriers to mainstream adoption

Because LLLT modulates cellular oxidation and energy production it could potentially affect  a wide range of diseases, injuries or other dysfunctions in the body.

By the end of the next decade, it is possible  LLLT may be used in almost every department of every hospital (and every medicine cabinet of every home).

Given the amount of good quality research published over the last decade, why isn’t it part of mainstream medicine already?

Posted in PBM/LLLT, Special Feature, THE FUTURE OF PBM/LLLT | on The next decade of LLLT – the barriers to mainstream adoption